Platelet-derived growth factor (PDGF) and its receptor PDGFR are required for tumor growth and angiogenesis, so disruption of the PDGF-PDGFR interaction should lead to starvation of tumors and reduction of tumor growth. Potent PDGF antagonists have been discovered through the synthesis of a series of calixarene-based compounds that are designed to bind to the three-loop region of PDGF. The effect of lower-rim alkylation, linker and number of interacting head groups on the calixarene scaffold on PDGF affinity and cellular activity has been investigated.
|Original language||English (US)|
|Number of pages||11|
|Journal||Organic and Biomolecular Chemistry|
|State||Published - 2006|
ASJC Scopus subject areas
- Physical and Theoretical Chemistry
- Organic Chemistry